INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
In the wake of the damage several tornadoes left behind in the Central Indiana area, Hoosiers are wondering how they can get involved and…
A man is dead after he was shot on Indianapolis' northeast side Wednesday evening.
Wednesday's tornado outbreak started with an EF2 tornado just south of Crawfordsville.
A Kokomo Starbucks usually known for a variety of coffees and a relaxed atmosphere turned into a frightening construction site after it was…
After more than 6 hours, at least 8 tornadoes and hundreds of homes and buildings damaged, a tornado outbreak in central Indiana has come to…